Jackson, David P <br/><br/>
The JAK/STAT pathway is not sufficient to sustain the antiproliferative response in an interferon-resistant human melanoma cell line.  [electronic resource] 

 -  Melanoma research  Jun 2003 
 - 219-29 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0960-8931 
<br/><br/><label>Standard No.: </label>10.1097/00008390-200306000-00001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Cell Division--drug effects<br/>DNA-Binding Proteins--drug effects<br/>Drug Resistance, Neoplasm--physiology<br/>Humans<br/>Interferons--pharmacology<br/>Janus Kinase 1<br/>Janus Kinase 2<br/>Janus Kinase 3<br/>Melanoma--drug therapy<br/>Protein-Tyrosine Kinases--metabolism<br/>Proto-Oncogene Proteins<br/>STAT1 Transcription Factor<br/>STAT2 Transcription Factor<br/>STAT3 Transcription Factor<br/>Signal Transduction<br/>Skin Neoplasms--drug therapy<br/>Trans-Activators--drug effects<br/>Tumor Cells, Cultured